Products

Main   |   Urinalysis Solutions   |   Microbiology Solutions   |   Collection Devices   |  
Catheter Solutions / UTI Management   |   Urine Ordering Information   |   How Can BD Help?

Catheter Associated Solutions & UTI Management

What changed?¹
CMS decided to disallow incremental payments associated with twelve categories of secondary conditions that it sees as preventable complications of medical care. These conditions, if not present on admission, will no longer be taken into account in calculating payments to hospitals after October 1, 2008.

Example²:
Patient admitted to a Boston-area hospital with pneumonia. Secondary condition developed, not POA: Urinary Tract Infection. Current payment to hospital = $6,253.58 (under DRG 89 pneumonia with complications). Payment under the new rule = $3,705.38 (under DRG 90 simple pneumonia) A difference of $2,548.20 ' a reduction of approximately 40%. Payment will be reduced only for instances in which preventable complications were the only factor causing a case to be reclassified under a higher paying DRG.

How will these changes impact your facility?
It is expected that facilities will have to increase the number of urine samples that will be sent to the laboratory to determine POA conditions. '' physicians and hospitals will increase urinalysis testing to identify urinary tract infections prior to admission.'' Public comments ' Federal Register: August 22, 2007 (Volume 72, Number 162), Page 47205.

How can BD help?
Determine if an infection is Present on Admission with a simple urinalysis test, monitor your foley catheter patients and provide a quality sample to perform a culture, in case it's later deemed necessary. BD tubes will help you streamline the urine collection process by:

• Drawing the sample from a cup/ Foley catheter to the tube without pouring-off
• Sending our leak-proof tubes through the pneumatic system
• Stabilizing the sample at room temperature for 72 hours (without preservative or refrigeration, bacteria develop after 2 hours following collection)
• Eliminating unnecessary steps and exposure by transferring the sample directly to the tube.
• Assessing culture and sensitivity with a quality sample, reducing mixed growth and subsequent need for, recollection of sample.

Product Materials

Click here to download product literature and E-Training Module

References
1 Federal Register / Vol 73, No. 161 / Tuesday August 19, 2008
2 The New England Journal of Medicine, Nonpayment for Performance? Medicare's New Reimbursement Rule / October 18, 2007

Safety   '   Efficiency   '   Clinical Utility   '   Employee Satisfaction